financetom
Business
financetom
/
Business
/
OPEC sees balanced oil market in 2026, moves further away from deficit projection
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
OPEC sees balanced oil market in 2026, moves further away from deficit projection
Nov 12, 2025 5:34 AM

LONDON (Reuters) -World oil supply is expected to match demand next year in a reflection of the wider OPEC+ group's production increases, an OPEC report showed on Wednesday, marking a further shift from its earlier projections of a supply deficit in 2026.

OPEC+, which groups the Organization of the Petroleum Exporting Countries, Russia and other allies, has raised its output targets by around 2.9 million barrels per day - or around 2.7% of global supply - since April.

It plans to pause production hikes in the first quarter of 2026 amid widespread predictions of an oversupply.

In a monthly report on Wednesday, OPEC said the world economy's growth trend remained firm.

While demand is seen as steady, OPEC said in the report that OPEC+ in October cut output by 73,000 bpd to 43.02 million bpd, despite the group's output hike agreement for the month, led by a drop in Kazakhstan.

Expected demand for OPEC+ crude at 43.0 million bpd in 2026 implies that the world market will see a marginal surplus of 20,000 bpd if the wider group keeps pumping at October's rate, according to a Reuters calculation based on the report.

Last month's report had projected a deficit of 50,000 bpd, and the September report pointed to a shortfall of 700,000 bpd.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Coinbase Global Shares Fall After Argus Downgrade
Coinbase Global Shares Fall After Argus Downgrade
Nov 25, 2025
03:10 PM EST, 11/25/2025 (MT Newswires) -- Coinbase Global ( COIN ) shares were down about 2.7% in recent Tuesday trading after Argus downgraded the stock to hold from buy. Trading volume stood at more than 6.1 million shares, compared with a daily average of almost 9.6 million. Price: 249.04, Change: -6.93, Percent Change: -2.71 ...
AstraZeneca's Imfinzi Regimen Approved in US for Early-Stage Stomach Cancer
AstraZeneca's Imfinzi Regimen Approved in US for Early-Stage Stomach Cancer
Nov 25, 2025
03:08 PM EST, 11/25/2025 (MT Newswires) -- AstraZeneca ( AZN ) said Tuesday its Imfinzi in combination with standard chemotherapy was approved in the US to treat adults with early-stage and locally advanced gastric and gastroesophageal junction cancers. The approval follows Priority Review by the Food and Drug Administration and is based on event-free survival and overall survival data from...
Best Buy Logs Strongest Domestic Comparable Sales Growth in 4 Years, Truist Says
Best Buy Logs Strongest Domestic Comparable Sales Growth in 4 Years, Truist Says
Nov 25, 2025
03:13 PM EST, 11/25/2025 (MT Newswires) -- Best Buy ( BBY ) posted the strongest increase in domestic comparable sales in about four years amid improvements in key categories, though a promotional environment could cap gains in future earnings, Truist Securities said Tuesday. Earlier in the day, the electronics retailer reported US same-store sales growth of 2.4% for its fiscal...
US FDA approves Otsuka's kidney disease drug
US FDA approves Otsuka's kidney disease drug
Nov 25, 2025
Nov 25 (Reuters) - The U.S. Food and Drug Administration has approved Otsuka's injectable drug to treat patients with a potentially life-threatening kidney disease, the health regulator's website showed on Tuesday. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved